Novocure Ltd
Status: Publicly traded
Direct answer
Novocure Ltd is publicly traded on NASDAQ under the ticker NVCR.
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain...
Can you invest in Novocure Ltd?
Yes. Novocure Ltd trades publicly on NASDAQ as NVCR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Novocure Ltd
Detailed equity research is provided by MarketSnap.